Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Clinical trial NCT02636725 · COMPLETED
Trial details
- NCT number
- NCT02636725
- Sponsor
- Jonathan Trent, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-19
- Primary completion
- 2018-05-08
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.